Viking Therapeutics Inc. Stock Quote (U.S. - VKTX - MarketWatch
4 days ago · VKTX | Complete Viking Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Viking Therapeutics' stock benefits as investors cheer ...
Feb 28, 2024 · Viking Therapeutics Inc.’s stock soared 121% Tuesday to close at a record high, after the company announced positive results from a Phase 2 trial of its weight-loss drug VK2735, a GLP-1 receptor ...
Viking Therapeutics reports positive data from trial of treatment …
Oct 9, 2024 · Viking Therapeutics Inc. on Wednesday reported positive data from an early-stage trial of a treatment for the rare, and often fatal, metabolic disorder X-linked adrenoleukodystrophy, or X-ALD.
Viking Therapeutics’ stock soars 18% as data on oral weight-loss …
Oct 24, 2024 · Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted ...
Viking Therapeutics' stock rallies after Madrigal shares positive …
Dec 19, 2022 · Madrigal Pharmaceuticals Inc. said Monday it is aiming to get an accelerated approval in the U.S. for its drug. Viking's treatment candidate is currently in a Phase 2b clinical trial. The company ...
Viking Therapeutics’ promising weight-loss drug data makes the …
Feb 29, 2024 · The news from Tuesday that a Phase 2 trial called Venture had produced positive data for its VK2735 weight-loss drug sent the stock VKTX up 121% to a record level and record one-day gain.
Viking Therapeutics takes advantage of soaring stock price to …
Mar 1, 2024 · The company, whose stock VKTX has gained an impressive 129% in the week so far, priced a $550 million offering of 6.47 million shares at $85 a share late Wednesday, a discount over its closing ...
Viking Therapeutics may offer investors a cheap entry to the …
Feb 10, 2024 · Biotech is expecting a readout from a trial of its GLP-1 drug in pill form in the first quarter. Viking Therapeutics Inc.’s stock soared 17% to a record high on Thursday, after the company said ...
Viking Therapeutics posts positive results for oral weight-loss drug ...
Mar 28, 2024 · The data showed the company’s VK2735 oral therapy achieved a 3.3% placebo-adjusted weight loss at day 28 based on a 40 mg dose and proved safe and well tolerated, raising hopes that higher doses ...
Company News and Releases - Viking Therapeutics Inc., VKTX …
Oct 24, 2024 · News Headlines for Viking Therapeutics Inc. Monday, Nov 04, 2024. Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial MarketWatch. 10:26 AM ET